Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2023 07:33 ET | Source: Research and Markets

Leukemia Therapeutics Global Market Report 2023: Rises in Product Approvals and Increasing Diagnosis Awareness Drives Growth

Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Leukemia Therapeutics Market by Type, Drug Class, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...
August 05, 2021 07:28 ET | Source: Research and Markets

Acute Myeloid Leukemia (AML) Market Insights & Epidemiology Analysis & Forecasts, 2018-2020 & 2021-2030: Major Markets, Marketed Therapies, Emerging Therapies, Case Reports, Patient Journey

Dublin, Aug. 05, 2021 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML)- Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. The...
July 06, 2021 08:08 ET | Source: Research and Markets

Global Chronic Lymphocytic Leukemia (CLL) Disorder Clinical Market Report 2021-2027

Dublin, July 06, 2021 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL)" report has been added to ResearchAndMarkets.com's offering. Chronic lymphocytic leukemia (CLL) is a disorder where...
April 12, 2021 06:58 ET | Source: Research and Markets

Global Multiple Myeloma Disease Coverage Forecast and Market Analysis Report 2021: Comprehensive Collection of All Recent Events that has Affected the Market and Future Trends

Dublin, April 12, 2021 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Disease Coverage Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering. Multiple myeloma is...
April 12, 2021 06:48 ET | Source: Research and Markets

Global Acute Myeloid Leukemia (AML) Disease Analysis Report 2021: On Average, it Takes 10.8 Years from Phase I to Approval, Compared to 9.6 Years in the Overall Oncology Space

Dublin, April 12, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Acute Myeloid Leukemia (AML)" report has been added to ResearchAndMarkets.com's offering. AML is a type of heterogeneous...
September 18, 2020 04:53 ET | Source: Research and Markets

Global Acute Myeloid Leukemia (AML) Disease Analysis Report 2020

Dublin, Sept. 18, 2020 (GLOBE NEWSWIRE) -- The "Disease Analysis: Acute Myeloid Leukemia (AML)" drug pipelines has been added to ResearchAndMarkets.com's offering. The publisher estimates that in...